BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22122678)

  • 21. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production.
    Dimitrov M; Alattia JR; Lemmin T; Lehal R; Fligier A; Houacine J; Hussain I; Radtke F; Dal Peraro M; Beher D; Fraering PC
    Nat Commun; 2013; 4():2246. PubMed ID: 23907250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.
    Pistell PJ; Zhu M; Ingram DK
    Neuroscience; 2008 Mar; 152(3):594-600. PubMed ID: 18304749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-amyloid precursor protein and early-onset Alzheimer's disease.
    Hendriks L; Jonghe CDXs ; Cras P; Martin JJ; Broeckhoven CV
    Ciba Found Symp; 1996; 199():170-80. PubMed ID: 8915610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amyloid precursor protein and Alzheimer's disease].
    Chen SD; Fang JJ
    Sheng Li Ke Xue Jin Zhan; 1993 Oct; 24(4):306-9. PubMed ID: 8202682
    [No Abstract]   [Full Text] [Related]  

  • 25. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
    Adalbert R; Milde S; Durrant C; Ando K; Stygelbout V; Yilmaz Z; Gould S; Brion JP; Coleman MP
    Neurobiol Aging; 2018 Aug; 68():68-75. PubMed ID: 29729423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function.
    Beyreuther K; Masters CL
    Brain Pathol; 1991 Jul; 1(4):241-51. PubMed ID: 1669714
    [No Abstract]   [Full Text] [Related]  

  • 29. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants.
    Gorman PM; Kim S; Guo M; Melnyk RA; McLaurin J; Fraser PE; Bowie JU; Chakrabartty A
    BMC Neurosci; 2008 Jan; 9():17. PubMed ID: 18234110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.
    Narukawa M; Takahashi S; Saito T; Saido TC; Misaka T
    J Alzheimers Dis; 2020; 76(3):997-1004. PubMed ID: 32568206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [APP, the causal gene for Alzheimer's disease].
    Tamaoka A; Kametani F
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1453-9. PubMed ID: 8741396
    [No Abstract]   [Full Text] [Related]  

  • 32. APP physiological and pathophysiological functions: insights from animal models.
    Guo Q; Wang Z; Li H; Wiese M; Zheng H
    Cell Res; 2012 Jan; 22(1):78-89. PubMed ID: 21769132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of Alzheimer's disease: molecular and cellular mechanisms].
    Govaerts L; Schoenen J; Bouhy D
    Rev Med Liege; 2007 Apr; 62(4):209-16. PubMed ID: 17566391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational analysis of Alzheimer-causing mutations in amyloid precursor protein and presenilin 1.
    Mehra R; Kepp KP
    Arch Biochem Biophys; 2019 Dec; 678():108168. PubMed ID: 31697913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of the Swedish APP670/671 mutation for the development of Alzheimer's disease amyloidosis.
    Johnston J; O'Neill C; Lannfelt L; Winblad B; Cowburn RF
    Neurochem Int; 1994 Jul; 25(1):73-80. PubMed ID: 7950974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog?
    Koo EH
    Traffic; 2002 Nov; 3(11):763-70. PubMed ID: 12383342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance.
    Tomiyama T; Shimada H
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single App knock-in mouse models of Alzheimer's disease.
    Saito T; Matsuba Y; Mihira N; Takano J; Nilsson P; Itohara S; Iwata N; Saido TC
    Nat Neurosci; 2014 May; 17(5):661-3. PubMed ID: 24728269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
    Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
    J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.